ECSP982764A - PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE - Google Patents
PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASEInfo
- Publication number
- ECSP982764A ECSP982764A ECSP982764A ECSP982764A EC SP982764 A ECSP982764 A EC SP982764A EC SP982764 A ECSP982764 A EC SP982764A EC SP982764 A ECSP982764 A EC SP982764A
- Authority
- EC
- Ecuador
- Prior art keywords
- treatment
- methods
- prevention
- amyloidogenic disease
- disease
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 102000009091 Amyloidogenic Proteins Human genes 0.000 title 1
- 108010048112 Amyloidogenic Proteins Proteins 0.000 title 1
- 230000003942 amyloidogenic effect Effects 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 238000000034 method Methods 0.000 abstract 4
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 230000003941 amyloidogenesis Effects 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La invención provee composiciones y métodos para el tratamiento de enfermedades amilodogénicas. Dichos métodos abarcan la administración de un agente que induce una respuesta inmunitaria beneficiosa contra un depósito amiloide en el paciente. Los métodos son particularmente útiles para el tratamiento profiláctco y terapéutico de la enfermedad de Alzheimer. En dichos métodos, un agente apropiado es el péptido AB o un anticuerpo del mismo.The invention provides compositions and methods for the treatment of amylodogenic diseases. Such methods encompass the administration of an agent that induces a beneficial immune response against amyloid deposition in the patient. The methods are particularly useful for the prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, an appropriate agent is the AB peptide or an antibody thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982764 ECSP982764A (en) | 1998-12-01 | 1998-12-01 | PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982764 ECSP982764A (en) | 1998-12-01 | 1998-12-01 | PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP982764A true ECSP982764A (en) | 1999-05-06 |
Family
ID=42043683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP982764 ECSP982764A (en) | 1998-12-01 | 1998-12-01 | PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP982764A (en) |
-
1998
- 1998-12-01 EC ECSP982764 patent/ECSP982764A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200001608T2 (en) | Prevention and treatment of amyloidogenic disease | |
| UY26182A1 (en) | PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE | |
| AR041725A1 (en) | PREVENTION, TREATMENT OF SINUCLEINOPATIC DISEASE AND PHARMACOLOGICAL COMPOSITION | |
| SG147274A1 (en) | Prevention and treatment of amyloidogenic disease | |
| CO4290346A1 (en) | Azithromycin Controlled Release Dosage Forms | |
| ES2166111T3 (en) | USE OF TIAGABINE FOR THE TREATMENT OF SLEEP DISORDERS. | |
| AR026610A1 (en) | A PIRROLIDINACETAMIDE DERIVATIVE ONLY OR IN COMBINATION FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | |
| BR0016022A (en) | Vaccine for the prevention and treatment of alzheimer's disease and amyloid-related diseases | |
| NO20071267L (en) | Prevention and treatment of synucleinopathic and amyloidogenic diseases | |
| CY1115856T1 (en) | DOSAGE UNIT CONTAINS PROSTAGLENDIN ANALOG FOR THE PROTECTION OF CONSCIENCE | |
| EA200300560A1 (en) | IMPROVED TREATMENT METHOD | |
| BR0313413A (en) | Use of beta amyloid vaccination together with a selective cox-2 inhibitor for the treatment of alzheimer's disease | |
| AR023687A1 (en) | A COMPOSITION FOR THE TREATMENT OF EXTERNAL RETINA DISORDERS AND THE USE OF A GLUTAMATE ANTAGONIST FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF EXTERNAL RETINA DISORDERS | |
| ES2177024T3 (en) | EMPLOYMENT OF THE FANQUINOMA FOR THE TREATMENT OF ALZHEIMER'S DISEASE. | |
| NZ505538A (en) | A vaccine comprising immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide (PIM); and the use of PIM for inducing an immune response in a patient effective in the prevention or treatment of Th2-mediated diseases or disorders such as asthma | |
| ECSP982764A (en) | PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE | |
| BR0311180A (en) | Methods for treating respiratory diseases and conditions using a selective inhibitor of inos | |
| ECSP003492A (en) | PREVENTION AND TREATMENT OF AMILOIDOGENIC DISEASES | |
| AR015537A1 (en) | USE OF BRINZOLAMIDE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO TREAT OR PREVENT RETINA EDEMA. | |
| MD1610F1 (en) | Method of the recidivating chronic aphthous stomatitis treatment | |
| GT199500023A (en) | DOSAGE FORMS OF CONTROLLED RELEASE AZITHROMYCIN | |
| ECSP951438A (en) | Azithromycin Controlled Release Dosage Forms | |
| TR201900152T4 (en) | Prevention and treatment of synucleinopathic and amyloidogenic diseases. |